These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9373645)

  • 41. 'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients.
    Bourgeois N; Bastien P; Reynes J; Makinson A; Rouanet I; Lachaud L
    HIV Med; 2010 Nov; 11(10):670-3. PubMed ID: 20500233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Visceral leishmaniasis and human immunodeficiency virus (HIV) infection in the south of France].
    Rosenthal E; Marty P; Cassuto JP
    Presse Med; 1995 Nov; 24(35):1666. PubMed ID: 8545394
    [No Abstract]   [Full Text] [Related]  

  • 43. HIV and visceral leishmaniasis coinfection in Bihar, India: an underrecognized and underdiagnosed threat against elimination.
    Burza S; Mahajan R; Sanz MG; Sunyoto T; Kumar R; Mitra G; Lima MA
    Clin Infect Dis; 2014 Aug; 59(4):552-5. PubMed ID: 24814660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraspecific genetic variability in a population of Moroccan Leishmania infantum revealed by PCR-RFLP of kDNA minicircles.
    El Hamouchi A; Ejghal R; Hida M; Lemrani M
    Acta Trop; 2017 May; 169():142-149. PubMed ID: 28209553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atypical manifestations of visceral leishmaniasis in patients with HIV in north Ethiopia: a gap in guidelines for the management of opportunistic infections in resource poor settings.
    Diro E; van Griensven J; Mohammed R; Colebunders R; Asefa M; Hailu A; Lynen L
    Lancet Infect Dis; 2015 Jan; 15(1):122-9. PubMed ID: 25300862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals.
    van Griensven J; Diro E; Lopez-Velez R; Boelaert M; Lynen L; Zijlstra E; Dujardin JC; Hailu A
    Lancet Infect Dis; 2013 Mar; 13(3):251-9. PubMed ID: 23427890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphoproliferative response after stimulation with soluble leishmania antigen (SLA) as a predictor of visceral leishmaniasis (VL) relapse in HIV+ patients.
    Castro A; Carrillo E; San Martín JV; Botana L; Molina L; Matía B; Fernandez L; Horrillo L; Ibarra-Meneses A; Sanchez C; Ruiz-Giardin JM; Moreno J
    Acta Trop; 2016 Dec; 164():345-351. PubMed ID: 27693332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploring prognosis in chronic relapsing visceral leishmaniasis among HIV-infected patients: Circulating Leishmania DNA.
    Cota GF; de Sousa MR; de Assis TSM; Pinto BF; Rabello A
    Acta Trop; 2017 Aug; 172():186-191. PubMed ID: 28501450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network.
    Zhao C; Papadopoulou B; Tremblay MJ
    Clin Immunol; 2004 Oct; 113(1):81-8. PubMed ID: 15380533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antileishmanial activity of antiretroviral drugs combined with miltefosine.
    Costa S; Machado M; Cavadas C; do Céu Sousa M
    Parasitol Res; 2016 Oct; 115(10):3881-7. PubMed ID: 27249967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Visceral leishmaniasis as an opportunistic infection. Case report and literature review].
    Moradpour D; Markwalder K; Greminger P; Lüthy R
    Schweiz Rundsch Med Prax; 1990 Aug; 79(31-32):921-6. PubMed ID: 2203128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uveitis secondary to leishmaniasis immune reconstitution syndrome in a HIV-positive patient.
    Davies O; Allen F; Gruener AM; Simons R; Graham EM; Larbalestier N
    Int J STD AIDS; 2016 Jun; 27(7):598-600. PubMed ID: 26002317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology of human immunodeficiency virus-visceral leishmaniasis-co-infection.
    Naufal Spir PR; Zampieri D'Andrea LA; Fonseca ES; Prestes-Carneiro LE
    J Microbiol Immunol Infect; 2016 Apr; 49(2):295-9. PubMed ID: 23834783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of two immunochromatographic tests for diagnosis of visceral leishmaniasis in patients coinfected with HIV.
    da Silva MRB; Brandão NAA; Colovati M; de Sousa MMP; de Lima LC; Dorta ML; Ribeiro-Dias F; Costa DL; Costa CHN; de Oliveira MAP
    Parasitol Res; 2018 Feb; 117(2):419-427. PubMed ID: 29270768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Leishmania infection and AIDS].
    Hernández Quero J; Carvajal Becerra F; Escobar Lara T; López Ruz MA; Vélez Bernal ID; de La Higuera JM
    An Med Interna; 1993 Jun; 10 Suppl():29-33. PubMed ID: 8507799
    [No Abstract]   [Full Text] [Related]  

  • 56. Variability of Leishmania (Leishmania) infantum among stocks from immunocompromised, immunocompetent patients and dogs in Spain.
    Jiménez M; Ferrer-Dufol M; Cañavate C; Gutiérrez-Solar B; Molina R; Laguna F; López-Vélez R; Cercenado E; Daudén E; Blázquez J
    FEMS Microbiol Lett; 1995 Sep; 131(2):197-204. PubMed ID: 7557330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Usefulness of immunoblot in the serologic diagnosis of visceral leishmaniasis in patients with the human immunodeficiency virus].
    Cardeñosa N; Cortés P; Muñoz C
    Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):629-30. PubMed ID: 9053013
    [No Abstract]   [Full Text] [Related]  

  • 58. Visceral leishmaniasis as a cause of diarrhoea in HIV-infected patients.
    Pulido F; Rubio R; Costa JR
    AIDS; 1995 Jun; 9(6):661-2. PubMed ID: 7662216
    [No Abstract]   [Full Text] [Related]  

  • 59. Unusual presentation of visceral leishmaniasis in an HIV-infected patient.
    Cenderello G; Pontali E; Ruggeri C; Dusi A; De Maria A
    AIDS Res Hum Retroviruses; 2014 Sep; 30(9):846-7. PubMed ID: 25054214
    [No Abstract]   [Full Text] [Related]  

  • 60. Leishmania infection occurring in herpes zoster lesions in an HIV positive patient.
    Del Giudice P
    Br J Dermatol; 1996 Dec; 135(6):1005-6. PubMed ID: 8977732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.